July 16, 2021
(Reuters) – The U.S. Food and Drug Administration set a deadline of January next year for its review of Pfizer and BioNTech SE’s COVID-19 vaccine’s use in people 16 years of age and older, the companies said on Friday.
(Reporting by Manojna Maddipatla in Bengaluru)